Filed: 5/15/2024ACC: 0001172661-24-002523
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $641.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$641.64M
Total AUM (reported)
52.44M
Total Shares
Allocation by class
COM$471.56M73.5%
COM NEW$65.38M10.2%
SPONSORED ADS$35.59M5.5%
COM PAR $.01$21.04M3.3%
COMMON STOCK$20.86M3.3%
ADS$7.47M1.2%
SPON ADS$7.44M1.2%
Portfolio Concentration
Top 3$135.16M21.1%
4–10$195.68M30.5%
11–25$246.66M38.4%
Rest$64.14M10.0%
Top 3 weight
21.1%
Top 10 weight
51.6%
Voting Authority Distribution
Total shares with voting rights: 52.44M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
52.44M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other35
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings35
Rows:
NEUROGENE INC
DFNDShares1M
TypeSH
Market value$51.12M
7.97%
Sole
0.00
Shared
1M
None
0.00
ALPINE IMMUNE SCIENCES INC
DFNDShares1.13M
TypeSH
Market value$44.73M
6.97%
Sole
0.00
Shared
1.13M
None
0.00
UROGEN PHARMA LTD
DFNDShares2.62M
TypeSH
Market value$39.31M
6.13%
Sole
0.00
Shared
2.62M
None
0.00
ABIVAX SA
DFNDShares2.49M
TypeSH
Market value$35.59M
5.55%
Sole
0.00
Shared
2.49M
None
0.00
EVOLUS INC
DFNDShares2.45M
TypeSH
Market value$34.30M
5.35%
Sole
0.00
Shared
2.45M
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares1.85M
TypeSH
Market value$27.59M
4.30%
Sole
0.00
Shared
1.85M
None
0.00
APOGEE THERAPEUTICS INC
DFNDShares400K
TypeSH
Market value$26.58M
4.14%
Sole
0.00
Shared
400K
None
0.00
AEROVATE THERAPEUTICS INC
DFNDShares887.69K
TypeSH
Market value$26.25M
4.09%
Sole
0.00
Shared
887.69K
None
0.00
VIRIDIAN THERAPEUTICS INC
DFNDShares1.33M
TypeSH
Market value$23.38M
3.64%
Sole
0.00
Shared
1.33M
None
0.00
ANAPTYSBIO INC
DFNDShares976.98K
TypeSH
Market value$22.00M
3.43%
Sole
0.00
Shared
976.98K
None
0.00
ESPERION THERAPEUTICS INC NE
DFNDShares8M
TypeSH
Market value$21.44M
3.34%
Sole
0.00
Shared
8M
None
0.00
INSMED INC
DFNDShares775.59K
TypeSH
Market value$21.04M
3.28%
Sole
0.00
Shared
775.59K
None
0.00
ARCELLX INC
DFNDShares300K
TypeSH
Market value$20.86M
3.25%
Sole
0.00
Shared
300K
None
0.00
XENON PHARMACEUTICALS INC
DFNDShares456.15K
TypeSH
Market value$19.64M
3.06%
Sole
0.00
Shared
456.15K
None
0.00
MIND MEDICINE MINDMED INC
DFNDShares2M
TypeSH
Market value$18.80M
2.93%
Sole
0.00
Shared
2M
None
0.00
DIANTHUS THERAPEUTICS INC
DFNDShares625K
TypeSH
Market value$18.75M
2.92%
Sole
0.00
Shared
625K
None
0.00
OUTLOOK THERAPEUTICS INC
DFNDShares1.48M
TypeSH
Market value$17.67M
2.75%
Sole
0.00
Shared
1.48M
None
0.00
AMICUS THERAPEUTICS INC
DFNDShares1.50M
TypeSH
Market value$17.62M
2.75%
Sole
0.00
Shared
1.50M
None
0.00
OCULAR THERAPEUTIX INC
DFNDShares1.73M
TypeSH
Market value$15.73M
2.45%
Sole
0.00
Shared
1.73M
None
0.00
DYNAVAX TECHNOLOGIES CORP
DFNDShares1.26M
TypeSH
Market value$15.70M
2.45%
Sole
0.00
Shared
1.26M
None
0.00
CYTOKINETICS INC
DFNDShares202.20K
TypeSH
Market value$14.18M
2.21%
Sole
0.00
Shared
202.20K
None
0.00
OPTINOSE INC
DFNDShares8.79M
TypeSH
Market value$12.83M
2.00%
Sole
0.00
Shared
8.79M
None
0.00
JASPER THERAPEUTICS INC
DFNDShares407.55K
TypeSH
Market value$11.97M
1.86%
Sole
0.00
Shared
407.55K
None
0.00
INTRA-CELLULAR THERAPIES INC
DFNDShares150K
TypeSH
Market value$10.38M
1.62%
Sole
0.00
Shared
150K
None
0.00
MERUS N V
DFNDShares223.29K
TypeSH
Market value$10.05M
1.57%
Sole
0.00
Shared
223.29K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEUROGENE INCDFND | COM | 1M | SH | $51.12M 7.97% | 0.00 | 1M | 0.00 |
ALPINE IMMUNE SCIENCES INCDFND | COM | 1.13M | SH | $44.73M 6.97% | 0.00 | 1.13M | 0.00 |
UROGEN PHARMA LTDDFND | COM | 2.62M | SH | $39.31M 6.13% | 0.00 | 2.62M | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.49M | SH | $35.59M 5.55% | 0.00 | 2.49M | 0.00 |
EVOLUS INCDFND | COM | 2.45M | SH | $34.30M 5.35% | 0.00 | 2.45M | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 1.85M | SH | $27.59M 4.30% | 0.00 | 1.85M | 0.00 |
APOGEE THERAPEUTICS INCDFND | COM | 400K | SH | $26.58M 4.14% | 0.00 | 400K | 0.00 |
AEROVATE THERAPEUTICS INCDFND | COM | 887.69K | SH | $26.25M 4.09% | 0.00 | 887.69K | 0.00 |
VIRIDIAN THERAPEUTICS INCDFND | COM | 1.33M | SH | $23.38M 3.64% | 0.00 | 1.33M | 0.00 |
ANAPTYSBIO INCDFND | COM | 976.98K | SH | $22.00M 3.43% | 0.00 | 976.98K | 0.00 |
ESPERION THERAPEUTICS INC NEDFND | COM | 8M | SH | $21.44M 3.34% | 0.00 | 8M | 0.00 |
INSMED INCDFND | COM PAR $.01 | 775.59K | SH | $21.04M 3.28% | 0.00 | 775.59K | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 300K | SH | $20.86M 3.25% | 0.00 | 300K | 0.00 |
XENON PHARMACEUTICALS INCDFND | COM | 456.15K | SH | $19.64M 3.06% | 0.00 | 456.15K | 0.00 |
MIND MEDICINE MINDMED INCDFND | COM NEW | 2M | SH | $18.80M 2.93% | 0.00 | 2M | 0.00 |
DIANTHUS THERAPEUTICS INCDFND | COM | 625K | SH | $18.75M 2.92% | 0.00 | 625K | 0.00 |
OUTLOOK THERAPEUTICS INCDFND | COM | 1.48M | SH | $17.67M 2.75% | 0.00 | 1.48M | 0.00 |
AMICUS THERAPEUTICS INCDFND | COM | 1.50M | SH | $17.62M 2.75% | 0.00 | 1.50M | 0.00 |
OCULAR THERAPEUTIX INCDFND | COM | 1.73M | SH | $15.73M 2.45% | 0.00 | 1.73M | 0.00 |
DYNAVAX TECHNOLOGIES CORPDFND | COM NEW | 1.26M | SH | $15.70M 2.45% | 0.00 | 1.26M | 0.00 |
CYTOKINETICS INCDFND | COM NEW | 202.20K | SH | $14.18M 2.21% | 0.00 | 202.20K | 0.00 |
OPTINOSE INCDFND | COM | 8.79M | SH | $12.83M 2.00% | 0.00 | 8.79M | 0.00 |
JASPER THERAPEUTICS INCDFND | COM NEW | 407.55K | SH | $11.97M 1.86% | 0.00 | 407.55K | 0.00 |
INTRA-CELLULAR THERAPIES INCDFND | COM | 150K | SH | $10.38M 1.62% | 0.00 | 150K | 0.00 |
MERUS N VDFND | COM | 223.29K | SH | $10.05M 1.57% | 0.00 | 223.29K | 0.00 |
Page 1 of 2